MCA
PFE icon

MSH Capital Advisors’s Pfizer PFE Stock Holding History

MSH Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
53,407
-4,242
-7% -$111K 0.22% 102
2026
Q1 		$1.62M Sell
57,649
-1,387
-2% -$36.9K 0.34% 81
2025
Q4 		$1.47M Buy
59,036
+5,354
+10% +$135K 0.31% 87
2025
Q3 		$1.37M Buy
53,682
+10,050
+23% +$248K 0.37% 77
2025
Q2 		$1.06M Buy
43,632
+9,047
+26% +$211K 0.3% 91
2025
Q1 		$876K Buy
34,585
+485
+1% +$12.7K 0.27% 100
2024
Q4 		$905K Sell
34,100
-32,398
-49% -$879K 0.28% 94
2024
Q3 		$1.92M Sell
66,498
-306
-0.5% -$8.93K 0.59% 54
2024
Q2 		$1.87M Buy
66,804
+1,921
+3% +$52.9K 0.62% 51
2024
Q1 		$1.8M Sell
64,883
-423
-0.6% -$11.7K 0.63% 52
2023
Q4 		$1.88M Sell
65,306
-4,535
-6% -$137K 0.7% 46
2023
Q3 		$2.32M Buy
69,841
+5,704
+9% +$202K 0.91% 29
2023
Q2 		$2.35M Buy
64,137
+8,326
+15% +$324K 0.86% 35
2023
Q1 		$2.28M Buy
55,811
+582
+1% +$25.1K 0.97% 26
2022
Q4 		$2.83M Buy
55,229
+1,006
+2% +$48.2K 1.28% 17
2022
Q3 		$2.37M Sell
54,223
-30
-0.1% -$1.46K 1.17% 18
2022
Q2 		$2.84M Buy
54,253
+626
+1% +$31.9K 1.32% 15
2022
Q1 		$2.78M Buy
53,627
+3,595
+7% +$187K 1.15% 19
2021
Q4 		$2.95M Buy
+50,032
New +$2.48M 1.32% 16

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MSH Capital Advisors's PFE Position: Q2 2026 in Review

MSH Capital Advisors reduced its Pfizer (PFE) stake by 7.4% in Q2 2026, selling an estimated $111K and leaving 53,407 shares worth $1.29M. The position accounts for 0.22% of the portfolio, ranked #102.

MSH Capital Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.95M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MSH Capital Advisors held 53,407 shares of Pfizer worth $1.29M as of Q2 2026.
  • MSH Capital Advisors sold 4,242 Pfizer shares in Q2 2026, an estimated $111K.
  • Pfizer made up 0.22% of MSH Capital Advisors's portfolio in Q2 2026, its #102 holding.
  • MSH Capital Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • MSH Capital Advisors's Pfizer position peaked at $2.95M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.